November 04, 2021
3 min watch
Save
VIDEO: Ora focuses on growing category of anterior segment products
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
BOSTON – It is an exciting time for anterior segment, Ora senior vice president George Ousler said here at the American Academy of Optometry annual meeting.
Ora partnered with Oyster Point to generate data showing the fast onset of action and broad applicability of Tyrvaya (varenicline solution 0.03 mg), the first nasal spray approved for the treatment of signs and symptoms of dry eye disease, he said.
“This is the golden era of clinical research in anterior segment,” Ousler said. “We would love for those around us to participate.”
Published by:
Sources/Disclosures
Collapse
Source:
George Ousler
Disclosures:
Ousler reports being senior vice president, anterior segment, Ora.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.